Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI3K inhibitors

Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI3K inhibitors

US Patent 10722512 · Granted Jul 28, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32024
HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chron2023
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a pro2022
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32022
Biomarkers to identify patients that will respond to treatment and treating such2020
Combinations of histone deacetylase inhibitors and immunomodulatory drugs2018
Treatment of leukemia with histone deacetylase inhibitors2017
Treatment of leukemia with histone deacetylase inhibitors2017
Treatment of leukemia with histone deacetylase inhibitors2017
Biomarkers to identify patients that will respond to treatment and treating such2017
Biomarkers to identify patients that will respond to treatment and treating such2017
Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI32016